Symbols / MURA
MURA Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | 2025-11-06 08:00 | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | — |
| Price | — | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
Current target
—
Low
—
High
—
Mean
—
- Mural Oncology (Nasdaq: MURA) scheme with XOMA unit effective as Nasdaq listing ends - Stock Titan Fri, 05 Dec 2025 08
- Mural Oncology plc Announces Effective Date of Scheme Arrangement for Acquisition by XOMA Royalty Corporation - Quiver Quantitative Fri, 05 Dec 2025 08
- Mural Oncology (NASDAQ:MURA) Will Have To Spend Its Cash Wisely - simplywall.st ue, 05 Aug 2025 07
- Mural Oncology (Nasdaq: MURA) to Be Acquired by XOMA Royalty for $2.035 Cash - Stock Titan Wed, 26 Nov 2025 08
- Lawsuit Filed Against Stride, Inc. (LRN) After Shares Plummet Over 51% - Business Wire Wed, 12 Nov 2025 08
- Richtech Robotics Inc. Under Investigation After 20% Stock Drop - The AI Journal hu, 29 Jan 2026 08
- Hub Group Accounting Error Leads to Plunging Stock Price - National Today Fri, 06 Feb 2026 08
- Mural Oncology plc Announces Final Determination of Additional Price Per Share in Acquisition by XOMA Royalty Corporation - Quiver Quantitative Wed, 26 Nov 2025 08
- Mural Oncology (MURA) Stock Forecast and Price Target 2026 - MarketBeat Sat, 11 May 2024 13
- Ardent Health, Inc. (ARDT) Under Investigation After Shares Plummet Over 33% - Business Wire hu, 13 Nov 2025 08
- XOMA Royalty (Nasdaq: XOMA) completes $2.035 per share Mural Oncology takeover - Stock Titan Fri, 05 Dec 2025 08
- Mural Oncology stock target cut to $6 at H.C. Wainwright By Investing.com - Investing.com UK Wed, 26 Mar 2025 07
- White & Case advises on Murapol’s Warsaw Stock Exchange IPO - Whitecase.com Fri, 15 Dec 2023 08
- Capricor Therapeutics, Inc. (NASDAQ: CAPR) Securities Fraud Investigation; CAPR Investors Urged to Contact Award-Winning Firm, Gibbs Mura - Business Wire Fri, 11 Jul 2025 07
- MURA - Mural Oncology PLC Latest Stock News & Market Updates - Stock Titan Wed, 15 Nov 2023 12
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for MURA
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|